CMS’ Evidence Appraisal Guidance May Clarify CED Mystery To Industry
This article was originally published in The Gray Sheet
Executive Summary
A new CMS guidance document on evidentiary standards could provide more transparency on how the agency arrives at a decision to provide conditional national coverage for a technology while a firm generates additional evidence